- Centers & Specialties
- Clinical Interests
- Biomakers in thrombolysis therapy
- Neurointensive care
- Medical Education
- MD, Boston University School of Medicine
- Residency, Brigham and Women's Hospital
- Fellowship, Brigham and Women's Hospital
- Board Certifications
- Vascular Neurology
- Boston: Massachusetts General Hospital
- Charlestown: Spaulding Rehabilitation Hospital
- Patient Gateway
- Yes, learn more
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Harvard Pilgrim Health Plan - SSN
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- United Healthplan (non-HMO) - other
- Patient Age Group
- Research Summary
Sponsored by the National Institutes of Health (NINDS), the Clinical Proteomics Research Center (CPRC) explores the clinical applications of proteomic technology. The goals of the Clinical Proteomics Research Center are to explore neurovascular pathophysiology using a translational approach, to develop prognostic tools to guide clinical decision-making, and to discover new targets of therapeutic intervention at the bedside. Read more about CPRC research in the application of proteomic technology to clinical problem solving in neurovascular disease on our Research Project page.
Research Laboratory Website & Profile
Research Investigator Profile, Department of Neurology, Massachusetts General Hospital
- Michael D, Martin KC, Seger R, Ning MM, Baston R, Kandel ER. Repeated pulses of serotonin required for long-term facilitation activate mitogen-activated protein kinase in sensory neurons of Aplysia. Proc Natl Acad Sci USA. 1998;95(4):1864-9.
- Plotkin SR, Ning MM. Traumatic cervical spine disruption. N Engl J Med. 2001;345(15):1134-5.
- Greenberg SM, Eng JA, Ning MM, Smith EE, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke. 2004;35(6):1415-20.
- Ning MM, Furie KL. Preventing a second stroke in the young. Top Stroke Rehabil. 2004;11(2):40-50.
- Wang X, Tsuji K, Lee SR, Ning MM, Furie KL, Buchan AM, Lo EH. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35:2726-30.
Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present insights and opinions on methods for treating refractory heart failure, genetically determined arrhythmias and atrial fibrillation in an integrated, multispecialty program.
15 Parkman Street
Boston MA, 02114-3117
Phone 1: 617-726-8459
300 First Avenue
Charlestown MA, 02129-3109
Phone 1: 617-573-2624